The absence of any of these disciplines can lead to blind spots that can introduce risk, but they are not all created equal.
In general, the Asian markets have controlled the COVID-19 virus successfully outside of China, but its effect has still led to new developments and trends.
A look at IP litigation in 2019 and the year ahead, and some advice on how medical device companies can safeguard their intellectual property.
Whatever the demands of international regulators, it is public expectations that will ultimately dictate the need for life sciences companies to prepare complete and accurate product data that patients and healthcare providers can scrutinize on demand.
The revolution in data and technology should be pushing companies to focus on safeguarding intellectual property.
How are you protecting your IP and keeping talent from going overseas?
Within this large and growing market, some companies are capitalizing, while others are faltering.
There are several steps you can take to protect your IP and avoid medical device piracy in China.